“Trade Alert — Biopharma Firm Poised for an Upsurge” from Ben Benoy

What stock is being teased by the new Biotech Intel Trader?

By Travis Johnson, Stock Gumshoe, December 17, 2014

I hadn’t ever heard of Ben Benoy or the new Biotech Intel Trader that’s being published by Harry Dent’s company, but a few folks asked about it yesterday so I thought you might like a quick little answer to their teaser pitch.

And actually, it’ll be even quicker than usual… more on that in a moment.

Benoy’s strategy is, essentially, that he’s going to integrate a lot of data into automated systems that help give him trade alerts — presumably using some proprietary insight into what is and isn’t important. From the spiel, it sounds like their “dashboard” of info on stocks relies on both the chart signals and on social sentiment. That’s not unique to Benoy, of course, there are at least a half dozen companies trying to develop reasonable “prediction engines” t